Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	82.91	5.72	6.75	11.63	19.76
Cash & Short-Term Investments	82.91	5.72	6.75	11.63	19.76
Cash Growth	1349.43%	-15.23%	-41.97%	-41.15%	2370.22%
Other Receivables	0.41	0.05	0.04	0.16	0.11
Receivables	0.41	0.05	0.04	0.16	0.11
Prepaid Expenses	0.99	0.22	0.03	0.16	0.17
Total Current Assets	84.31	5.99	6.81	11.95	20.04
Property, Plant & Equipment	0.11	0.12	0.07	0.14	-
Other Intangible Assets	-	-	-	-	0
Total Assets	84.42	6.1	6.88	12.09	20.04
Accounts Payable	1.71	0.41	0.18	1.25	0.6
Accrued Expenses	0.54	0.04	0.03	0.16	0.04
Current Portion of Leases	0.08	0.08	0.07	0.07	-
Total Current Liabilities	2.34	0.53	0.28	1.47	0.64
Long-Term Leases	0.04	0.04	-	0.07	-
Total Liabilities	2.38	0.57	0.28	1.54	0.64
Common Stock	123.25	35.42	33.91	32.24	27.08
Retained Earnings	-46.58	-34.35	-31.55	-24.17	-9.21
Comprehensive Income & Other	5.37	4.46	4.23	2.48	1.53
Shareholders' Equity	82.04	5.54	6.6	10.54	19.4
Total Liabilities & Equity	84.42	6.1	6.88	12.09	20.04
Total Debt	0.13	0.12	0.07	0.14	-
Net Cash (Debt)	82.78	5.6	6.67	11.49	19.76
Net Cash Growth	1377.97%	-16.08%	-41.90%	-41.86%	2370.22%
Net Cash Per Share	12.04	1.30	1.79	4.65	11.01
Filing Date Shares Outstanding	7.79	6.99	4.46	3.74	2.37
Total Common Shares Outstanding	7.64	4.52	3.77	3.52	2.37
Working Capital	81.97	5.46	6.53	10.48	19.4
Book Value Per Share	10.74	1.22	1.75	3.00	8.20
Tangible Book Value	82.04	5.54	6.6	10.54	19.4
Tangible Book Value Per Share	10.74	1.22	1.75	3.00	8.20

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q